Literature DB >> 7354119

Cushing's disease: management by transsphenoidal pituitary microsurgery.

S T Bigos, M Somma, E Rasio, R C Eastman, A Lanthier, H H Johnston, J Hardy.   

Abstract

Over 15 yr, 24 patients underwent transsphenoidal pituitary surgery for Cushing's disease with a median follow-up of 12 months. Cures included 7 patients with normal sella turcicas (6 microadenomas), 6 patients with focal depressions (6 microadenomas) of the sella (grade I), and 3 patients (3 adenomas) with enlarged sellas (grade II). Three patients with sella destruction (grades III and IV), 2 with normal sellas, and 1 with focal sella depression (grade I) were not cured. Two apparent cures (microadenomas) recurred. Tumor histology revealed 19 basophilic adenomas; electron microscopy (14 tumors) and immunochemical studies (10 tumors) revealed only ACTH cells. Circadian rhythm returned in 6 cured patients. Impotence (in 2), amenorrhea (in 7), and galactorrhea (in 3) resolved in affected cured patients. The major surgical complication was hemorrhage at the operative site (3 patients). Transsphenoidal pituitary surgery is a valuable method for managing Cushing's disease in many patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354119     DOI: 10.1210/jcem-50-2-348

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

2.  Recurrent Cushing's disease with low adrenal androgen production.

Authors:  R J Louard; R A Gelfand
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

3.  Results of adrenal surgery for Cushing's syndrome: 10 years' experience.

Authors:  R G Watson; J A van Heerden; R C Northcutt; C S Grant; D M Ilstrup
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

4.  Recurrence of Cushing's disease due to corticotrophe hyperplasia following transphenoidal hypophysectomy.

Authors:  J D Clark; T Wheatley; S Stewart; O M Edwards
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

5.  Long-term follow up of trans-sphenoidal hypophysectomy for Cushing's disease.

Authors:  I R Brand; G A Dalton; R F Fletcher
Journal:  J R Soc Med       Date:  1985-04       Impact factor: 5.344

6.  The pituitary before and after adrenalectomy for Cushing's syndrome.

Authors:  K J Manolas; H M Farmer; H K Wilson; A L Kennedy; G F Joplin; D A Montgomery; T L Kennedy; R B Welbourn
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

7.  Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.

Authors:  G Verde; P Loli; M E Berselli; M Tagliaferri; D Dallabonzana; G Oppizzi; A Liuzzi; P G Chiodini; G Luccarelli; S Lodrini
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

8.  In-vitro secretion of ACTH in Nelson's syndrome.

Authors:  D K Lüdecke; M Schabet; M Westphal; W Saeger
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

9.  Pituitary function before and after transsphenoidal adenomectomy in patients with Cushing's disease.

Authors:  B Ambrosi; M Giovanelli; S M Gaini; D Bochicchio; E Riva; G Tomei; M Zavanone; G Faglia
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

10.  Evaluation of surgically treated Nelson's syndrome.

Authors:  D K Lüdecke; H J Breustedt; J Brämswig; J Köbberling; W Saeger
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.